It follows that the dysregulation of PIM1, SOCS3 and BCL3 in circulating CD4+ T cells, which is mediated by aberrant STAT3 activation, is a distinguishing feature of early RA that occurs independently of the acute phase response. The gene discussed is BCL3; the disease is rheumatoid arthritis.